Detalhe da pesquisa
1.
Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment.
CNS Spectr
; 28(1): 90-97, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657638
2.
Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life.
Ann Gen Psychiatry
; 21(1): 20, 2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725552
3.
Emotional blunting in patients with depression. Part III: relationship with psychological trauma.
Ann Gen Psychiatry
; 21(1): 21, 2022 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729621
4.
Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptions.
Ann Gen Psychiatry
; 21(1): 22, 2022 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35733157
5.
Emotional blunting in patients with depression. Part I: clinical characteristics.
Ann Gen Psychiatry
; 21(1): 10, 2022 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379283
6.
Efficacy of vortioxetine in working patients with generalized anxiety disorder.
CNS Spectr
; 24(2): 249-257, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29081307
7.
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
Int J Neuropsychopharmacol
; 21(5): 442-447, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29546401
8.
Efficacy of vortioxetine in working patients with generalized anxiety disorder- ERRATUM.
CNS Spectr
; 24(2): 275, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880074
9.
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets.
J Psychopharmacol
; 38(2): 156-161, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38126222
10.
Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder.
Neuropsychiatr Dis Treat
; 20: 49-60, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239870
11.
Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study.
J Affect Disord
; 338: 423-431, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315590
12.
Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.
J Psychopharmacol
; 37(3): 279-288, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36377523
13.
The Motivation and Energy Inventory (MEI): Analysis of the clinically relevant response threshold in patients with major depressive disorder and emotional blunting using data from the COMPLETE study.
J Affect Disord
; 323: 547-553, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36395989
14.
Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy: Results of the VIVRE Study.
J Clin Psychiatry
; 84(4)2023 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227402
15.
Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability.
J Affect Disord
; 328: 345-354, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708956
16.
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.
Neuropsychiatr Dis Treat
; 19: 2401-2412, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029050
17.
Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study.
J Psychopharmacol
; 36(5): 566-577, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499104
18.
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study.
Neuropsychiatr Dis Treat
; 18: 1963-1974, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068858
19.
Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer's disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea.
Front Aging Neurosci
; 14: 1037816, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36698860
20.
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study.
Front Psychiatry
; 13: 824831, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35356713